Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.31% inched 0.60% higher to $164.34 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.54% rising 0.31% to 4,701.21 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.02% rising 0.10% to 35,754.75. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $15.58 short of its 52-week high ($179.92), which the company reached on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.65% rose 0.75% to $397.98, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.82% rose 1.29% to $73.21, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.44% fell 0.62% to $51.40. Trading volume (6.2 M) remained 1.0 million below its 50-day average volume of 7.2 M.